Filing Details
- Accession Number:
- 0000899243-19-001157
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2019-01-14 21:09:14
- Reporting Period:
- 2018-11-12
- Accepted Time:
- 2019-01-14 21:09:14
- Original Submission Date:
- 2018-11-14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501134 | Invitae Corp | NVTA | Services-Medical Laboratories (8071) | 271701898 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1640322 | L Robert Nussbaum | C/O Invitae Corporation 1400 16Th Street San Francisco CA 94103 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-11-12 | 8,244 | $13.00 | 171,191 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-11-12 | 2,200 | $13.53 | 168,991 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on August 10, 2018.
- The transaction code was incorrectly reported and transactions not within a one dollar price range were inadvertently aggregated on the reporting person's original Form 4.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $12.40 to $13.38.
- Includes an aggregate of 164,235 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- Represents weighted average sale price. Actual sale prices ranged from $13.40 to $13.66.
Billionaire Hedge Funds
